Clopidogrel (Plavix): dental considerations of an antiplatelet drug.
Wynn
R L
RL
Department of Oral-Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
Bergman
S A
SA
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001777:Blood Coagulation / Q000502:physiology; D000077144:Clopidogrel; D017742:Dental Care for Chronically Ill; D004347:Drug Interactions; D062787:Drug Overdose; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010974:Platelet Aggregation / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013988:Ticlopidine / Q000009:adverse effects* / Q000031:analogs & derivatives
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin